Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD [NA]

View source ↗

Summary

The LEOPARD trial is evaluating liquid biopsy as a prognostic and response diagnostic tool for Ewing sarcoma (bone and soft tissue), Peripheral primitive neuroe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ewing Sarcoma, Ewing Sarcoma of Bone | NA | Status: RECRUITING